{'fraction_non_alphanumeric': 0.018551236749116608, 'fraction_numerical': 0.007067137809187279, 'mean_word_length': 5.0588235294117645, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Carcinoma of the Prostate following Prostatectomy for Benign Hyperplasia: A ten-year retrospective study

It has been well-documented that prostatectomy for benign hyperplasia of the prostate, i.e, the enucleation of adenomatous prostate tissue, does not exclude the possibility of cancerous growth in the true prostate tissue remaining. (1.7) Current methods for the surgical treatmente of benign hyperplasia of the prostate result in the removal of the inner, periurethral part of the gland while the outer part adjacent to the prostatic capsule is untouched. It has been shown that in the vast majority of cases the prostatic cancer develops in this outer part of the gland, which embryologically stems from the posterior lobes. (7.12) In view of these facts, one would expect the incidence of cancerous growth in patients following prostatectomy for benign hyperplasia to be only slightly less than that in the general population. A review of the patients hospitalised for enlargement of the prostate over a period of 10 years revealed only 6 cases that had developed cancer of the prostate after surgery for benign hyperplasia.